FDA Approves Fenfluramine for Lennox-Gastaut Syndrome: Phase 3 Clinical Data Finds It Is Effective

No abstract available

Source: Neurology Today - June 16, 2022 Category: Neurology Tags: For Your Patients Source Type: research